CAS: 1234015-52-1 - 5-[[5-[2-(3-Aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-2-pyrazinecarbonitrile
Fórmula:C18H19N7O2
InChI:InChI=1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25)
Chave InChI:InChIKey=DOTGPNHGTYJDEP-UHFFFAOYSA-N
SMILES:N#CC1=NC=C(N=C1)NC2=NNC(=C2)C=3C(OC)=CC=CC3OCCCN
- Sinónimos:
- 2-Pyrazinecarbonitrile, 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-
- 5-[[5-[2-(3-Aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]-2-pyrazinecarbonitrile
- LY 2606368
- Prexasertib
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
LY 2606368 REF: IN-DA009CCUCAS: 1234015-52-1 | 98% | A consultar | Qui 05 Dez 24 | |
Prexasertib REF: TM-T4310CAS: 1234015-52-1 | 100% - 97.3% | 52,00 €~1.476,00 € | Qui 12 Dez 24 | |
LY 2606368 REF: TR-L486550CAS: 1234015-52-1 | - - - | 13.268,00 € | Qua 15 Jan 25 | |
LY2606368 REF: 3D-FA161375CAS: 1234015-52-1 | Min. 95% | A consultar | Qui 16 Jan 25 |
Ref: IN-DA009CCU
10mg | 173,00 € | ||
25mg | 247,00 € | ||
50mg | 523,00 € | ||
100mg | 591,00 € | ||
250mg | A consultar |
Prexasertib
Ref: TM-T4310
1mg | 52,00 € | ||
2mg | 80,00 € | ||
5mg | 119,00 € | ||
10mg | 179,00 € | ||
25mg | 350,00 € | ||
50mg | 513,00 € | ||
100mg | 731,00 € | ||
500mg | 1.476,00 € |
LY 2606368
Produto ControladoRef: TR-L486550
25mg | 13.268,00 € |
LY2606368
Ref: 3D-FA161375
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |